In human chronic lymphocytic leukemia (CLL), PPARα expression and activity increased by treatment with the synthetic glucocorticoid dexamethasone in vitro, and adipocyte-derived lipids, lipoproteins, and propionic acid conferred resistance to dexamethasone [141]. This evidence concerns the gene PPARA and B-cell chronic lymphocytic leukemia.